Filing Details

Accession Number:
0000899243-21-034143
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-25 16:15:51
Reporting Period:
2021-08-23
Accepted Time:
2021-08-25 16:15:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
313143 Haemonetics Corp HAE Surgical & Medical Instruments & Apparatus (3841) 042882273
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1682069 Mr. P. William Burke 125 Summer Street
Boston MA 02110
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-23 11,232 $34.21 41,523 No 4 M Direct
Common Stock Acquisiton 2021-08-23 11,435 $41.64 52,958 No 4 M Direct
Common Stock Disposition 2021-08-23 22,667 $60.51 30,291 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2021-08-23 11,232 $0.00 11,232 $34.21
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2021-08-23 11,435 $0.00 11,435 $41.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-10-25 2023-10-25 No 4 M Direct
0 2021-06-06 2024-06-06 No 4 M Direct
Footnotes
  1. Transaction pursuant to an existing 10b5-1 trading plan.
  2. Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $60.06 to $60.88, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. This number includes unvested RSUs previously reported.